Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Grant of 1,93,000 ESOP'.

JAGSNPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+2.4%1-day move

₹203.65

prior close

₹201.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.9+0.9+0.6+0.6+2.4+2.3+5.6+3.1+3.1+6.7-2.2+1.2+13.0—

Up moveDown movePending

AI summary

Jagsonpal Pharmaceuticals Limited has announced the grant of 1,93,000 employee stock options (ESOPs) under its Employees Stock Option Plan, 2022. The options have been granted at an exercise price of Rs. 159.50 per option. Each option is convertible into one equity share of face value Rs. 2.00. The vesting schedule is spread over 4 equal annual tranches, with the first tranche vesting on the first anniversary of the grant date. The grant was approved by the Nomination and Remuneration Committee on April 27, 2026.

Likely market impact

ESOP grants align employee interests with shareholders and can help retain talent, but result in potential share dilution for existing investors when options are exercised. The impact on per-share value depends on the current market price versus the Rs. 159.50 exercise price.